Quetiapine
- Schizophrenia
- Bipolar I disorder (manic and depressive episodes)
- Major depressive disorder (adjunctive)
- Insomnia
- Generalized anxiety
- Agitation in dementia (with significant caveats)
Side Effects Worth Knowing
Metabolic syndrome
Weight gain, hyperglycemia, dyslipidemia. Present at all doses due to H1 blockade. Requires monitoring: fasting glucose, lipid panel, weight, and waist circumference. This applies even at 25mg, a point many prescribers underappreciate.
Orthostatic hypotension
Alpha-1 blockade. Most significant during initiation and dose increases. Higher risk in elderly patients and those on antihypertensives.
Sedation
H1 blockade. Most prominent at lower doses and early in treatment. Many patients develop tolerance to the sedating effect over weeks (the brain upregulates histamine receptors), which is why insomnia may return after initial improvement.
QTc prolongation
Dose-dependent. Requires ECG monitoring in patients with cardiac risk factors or those on other QTc-prolonging medications.
Black box warning
Like all antipsychotics, quetiapine carries the FDA boxed warning for increased mortality in elderly patients with dementia-related psychosis. This applies to the entire antipsychotic class.
See This Medication in Action
These case studies show how quetiapine decisions play out in real clinical scenarios:
References & Further Reading
This page synthesizes information from standard clinical references. Consult primary sources for all prescribing decisions.
- FDA-approved prescribing information — quetiapine (DailyMed)
- Stahl's Essential Psychopharmacology (5th Edition, Cambridge University Press)
- APA Practice Guideline for the Treatment of Schizophrenia (3rd Edition, 2020)
- APA Practice Guideline for the Treatment of Bipolar Disorder (currently under revision; refer to most recent APA guidance)
Test your Quetiapine knowledge
Review flashcards on dosing, side effects, and interactions, or build a custom quiz with board-style questions.